Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
1486 University of Houston (143374)
Principal Investigator: Tam,Vincent H
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 7,341
Exceeds $250,000 (Is it flagged?): No
Start and End Dates: 1/20/23 - 12/31/23
Restricted Research: YES
Academic Discipline: Pharmacy
Department, Center, School, or Institute: Pharmacy Practice & Translational Research
Title of Contract, Award, or Gift: EMERGENCE OF TONB-DEPENDENT RECEPTOR MEDIATED CEFIDEROCOL RESISTANCE AMONG MULTIDRUG-RESIDANT (MDR) PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES
Name of Granting or Contracting Agency/Entity:
Houston Methodist Research Institute
CFDA Link: HHS
93.855
Program Title:
n/a
CFDA Linked: Allergy, Immunology and Transplantation Research
Note:
Development and validation of LC-MS/MS assays for different pharmacological agents; PK/PD investigations involving an infection model – samples will be obtained to verify simulated pharmacokinetic (fluctuating drug concentration-time) profiles. The bacterial responses to simulated drug exposure(s) (i.e., correlated to the human equivalents after FDAapproved doses are given) will be examined. SAMs 1.1.1
Discussion: No discussion notes